Novartis sending one million medicine packs to Ukraine

25 April 2022 14:44

Related partners

Joint Chamber of Commerce

Related partners

Joint Chamber of Commerce

Supporting partner

Basel - Novartis has donated medication worth 25 million US dollars to Ukraine and neighboring regions. In so doing, the pharma giant is seeking to play its part in distributing medical supplies to people in the war zone as well as refugees fleeing the conflict. In Russia, meanwhile, the company will no longer be conducting any new clinical trials.

Novartis has donated over one million medicine packs to Ukraine and bordering countries. The value of this donation amounts to more than 25 million US dollars, according to a press release. In addition, the Basel-based pharma company has also donated a sum of 3 million US dollars to aid organizations working to support refugees in the region. Novartis has also stated that it is continuing to support employees and their families in Ukraine as well as those who have opted to flee to war.

The drug manufacturer is primarily supplying antibiotics, pain relief medication as well as cardiovascular and oncological treatments. “We remain committed to providing access to medicines to patients in every country where we operate”, the company writes in the press release. This includes Russia. However, Novartis has announced that for the foreseeable future it will no longer carry out any new clinical trials in Russia and will pause the enrolment of new study participants in existing trials taking place in the country.

Meanwhile, Novartis is making sure to comply with the international sanctions imposed on Russia. In this context, the company has suspended capital investments, media advertisements and other promotional activities in Russia.

Supporting partner

Swiss Pavilion Digital